Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Surg Oncol ; 42(4): 513-22, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26843445

ABSTRACT

OBJECTIVE: To compare perioperative and clinico-pathological outcomes of patients with early-stage cervical cancer who underwent robot-assisted radical hysterectomy (RRH) and open radical hysterectomy (ORH). METHODS: This retrospective multi-center study abstracted demographic, clinico-pathological and perioperative outcomes data from medical records of 491 cervical cancer patients treated with RRH (n = 259) ORH (n = 232) between 2005 and 2011 at two American and one Norwegian University Cancer Centres. RESULTS: Mean estimated blood loss (EBL) and transfusion rates were less for RRH than for ORH (97 vs. 49 mL, p < 0.001, and 3% vs. 7%, p = 0.018, respectively). Mean length of hospital stay (LOS) was significantly shorter in RRH versus ORH (1.8 vs. 5.1 days, p < 0.001). Mean operative time was longer for RRH than ORH (220 vs. 156 min, p < 0.001). Although overall complications were similar (p = 0.49), intra-operative complications were less common in the RRH group than ORH (4% vs. 10%, p = 0.004). In multivariate regression analyses longer operative time, less EBL and intra-operative complications, shorter LOS, and more pre-operative cone were significantly associated with RRH versus ORH. Recurrence and death rates were not statistically different for the two groups at a mean follow-up time of 39 months (p = 1.00 and p = 0.48, respectively). CONCLUSIONS: RRH had improved clinical outcomes compared to ORH in the treatment of early-stage cervical cancer in terms of EBL, intra-operative complications, transfusion rates, LOS, and pre-operative cone. Disease recurrence and survival were comparable for the two procedures.


Subject(s)
Hysterectomy/methods , Neoplasm Staging , Robotics/methods , Uterine Cervical Neoplasms/surgery , Female , Humans , Incidence , Middle Aged , Neoplasm Recurrence, Local/epidemiology , Norway/epidemiology , Prognosis , Retrospective Studies , Survival Rate/trends , United States/epidemiology , Uterine Cervical Neoplasms/diagnosis
3.
Eur J Gynaecol Oncol ; 27(5): 531-3, 2006.
Article in English | MEDLINE | ID: mdl-17139995

ABSTRACT

OBJECTIVE: The aim of this study was to describe the first robotic-assisted radical hysterectomy (Piver type III) and bilateral pelvic lymph node dissection for a patient with Stage Ib1 cervical carcinoma. CASE: A 43-year-old woman G1, P1, previously operated on due to endometriosis with removal of the left ovary and fallopian tube, came under our care. In addition, hysteroscopic myomectomy had been done two years before. Otherwise the patient was healthy. Preoperative conization histology revealed 6 mm of stromal infiltration. The patient was offered the da Vinci robotic Wertheim operation for the first time which was well accepted and she was discharged uneventfully on the 4th day postoperatively. Four months later at a routine check-up we found asymptomatic bilateral lymphocysts but otherwise normal status. CONCLUSION: It is fully possible to perform Piver type III laparoscopic radical hysterectomy using the da Vinci robotic system and it seems that radical dissection is much more precise than the conventional laparoscopic radical hysterectomy.


Subject(s)
Carcinoma in Situ/surgery , Carcinoma, Squamous Cell/surgery , Hysterectomy/methods , Lymph Node Excision/methods , Robotics , Uterine Cervical Neoplasms/surgery , Adult , Female , Humans , Laparoscopy/methods
4.
Gynecol Oncol ; 44(2): 161-5, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1544593

ABSTRACT

The presence of CA125 was assessed in peritoneal fluid from 70 patients with ovarian cancer and 32 control patients. The follow-up period ranged from 39 to 89 months (median, 56 months). The cutoff for normal peritoneal fluid CA125 levels was determined to be 250 U/ml. A positive correlation between the serum and peritoneal fluid CA125 levels was observed (P less than 0.001). Peritoneal fluid levels were higher than serum levels in all patients. Patients with evidence of active ovarian cancer showed higher peritoneal fluid CA125 levels than the control patients (P less than 0.001). Peritoneal fluid CA125 levels correlated inversely with survival (P = 0.004). The peritoneal fluid CA125 levels were higher in patients with bulky tumor than in those with small (less than 1 cm) tumors (P less than 0.001). Eight out of twenty-six patients with active cancer and available peritoneal cytology had a negative peritoneal cytology. Three of these patients showed elevated peritoneal fluid levels. Three patients out of twenty-four showed elevated peritoneal fluid CA125 levels at second-look laparotomy. These 3 patients had negative biopsies at second-look surgery, but relapsed during the observation period. At second-look laparotomy an elevated peritoneal fluid CA125 level may imply a bad prognosis, but a normal level does not exclude the presence of disease.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/analysis , Ascitic Fluid/immunology , Cystadenocarcinoma/immunology , Ovarian Neoplasms/immunology , Ascitic Fluid/pathology , Biopsy , Cystadenocarcinoma/epidemiology , Cystadenocarcinoma/pathology , Female , Follow-Up Studies , Humans , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Prognosis , Radioimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL
...